Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza

Molecular Pharmacology

Volumn 74, Issue 3, 2008, Pages 896-903

  Marsolais, David ^a   Hahm, Bumsuk ^b   Edelmann, Kurt H ^a   Walsh, Kevin B ^a   Guerrero, Miguel ^a   Hatta, Yasuko ^c   Kawaoka, Yoshihiro ^c,d   Roberts, Edward ^a   Oldstone, Michael B A ^a   Rosen, Hugh ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [5 (3,4 DIETHOXYPHENYL) 1,2,4 OXADIAZOL 3 YL] 2,3 DIHYDRO 1H INDEN 1 YLAMINO]ETHANOL; 2 AMINO 4 (4 HEPTYLOXYPHENYL) 2 METHYLBUTANOL; 2 AMINO 4 [4 (HEPTYLOXY)PHENYL] 2 METHYLBUTYL DIHYDROGEN PHOSPHATE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; BENZENE DERIVATIVE; CYM 5442; FINGOLIMOD; INDENE DERIVATIVE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEREOISOMERISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; IMMUNE TOLERANCE; INFLUENZA A VIRUS; LUNG; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PHOSPHORYLATION; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 50449085535     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048769     Document Type: Article

References (41)

1. Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, and Okusa MD (2006) Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 290:F1516-F1524.
2. Bandhuvula P, Tam YY, Oskouian B, and Saba JD (2005) The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J Biol Chem 280:33697-33700.
3. Baumgarth N and Kelso A (1996) Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur J Immunol 26:2189-2197.
4. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, Shortman K, Carbone FR, and Heath WR (2004) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci U S A 101:8670-8675.
5. Billich A, Bornancin F, Dévay P, Mechtcheriakova D, Urtz N, and Baumruker T (2003) Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278:47408-47415.
6. Bolick DT, Srinivasan S, Kim KW, Hatley ME, Clemens JJ, Whetzel A, Ferger N, Macdonald TL, Davis MD, Tsao PS, et al. (2005) Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 25:976-981.
7. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457.
8. Brinkmann V, Pinschewer DD, Feng L, and Chen S (2001) FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72:764-769.
9. Budde K, Schutz M, Glander P, Peters H, Waiser J, Liefeldt L, Neumayer HH, and Bohler T (2006) FTY720 (fingolimod) in renal transplantation. Clin Transplant 20 (Suppl 17):17-24.
10. Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, and von Herrath MG (2004) A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 114:1290-1298.
11. Czeloth N, Bernhardt G, Hofmann F, Genth H, and Förster R (2005) Sphingosine-1-phosphate mediates migration of mature dendritic cells. J Immunol 175:2960-2967.
12. Don AS, Martinez-Lamenca C, Webb WR, Proia RL, Roberts E, and Rosen H (2007) Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J Biol Chem 282:15833-15842.
13. Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, and Garcia JG (2007) Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 19:1754-1764.
14. Hahm B, Arbour N, and Oldstone MB (2004) Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 323:292-302.
15. Hahm B, Marsolais D, Edelmann KH, Hatta Y, Kawaoka Y, Rosen H, and Oldstone MB (2007) Chemical amelioration of T cell-mediated influenza injury with retention of antibody protection [abstract], in Workshop on Replication and Cell Biology of Negative Strand RNA Viruses; 2007 Sep 15-19; Evanston, IL.
16. Idzko M, Hammad H, van Nimwegen M, Kool M, Müller T, Soullié T, Willart MA, Hijdra D, Hoogsteden HC, and Lambrecht BN (2006) Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 116:2935-2944.
17. Kiuchi M, Adachi K, Kohara T, Minoguchi M, Hanano T, Aoki Y, Mishina T, Arita M, Nakao N, Ohtsuki M, et al. (2000) Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J Med Chem 43:2946-2961.
18. Kiuchi M, Adachi K, Kohara T, Teshima K, Masubuchi Y, Mishina T, and Fujita T (1998) Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720. Bioorg Med Chem Lett 8:101-106.
19. Lan YY, De Creus A, Colvin BL, Abe M, Brinkmann V, Coates PT, and Thomson AW (2005) The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 5:2649-2659.
20. Le Stunff H, Peterson C, Liu H, Milstien S, and Spiegel S (2002) Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim Biophys Acta 1582:8-17.
21. Ledgerwood LG, Lal G, Zhang N, Garin A, Esses SJ, Ginhoux F, Merad M, Peche H, Lira SA, Ding Y, et al. (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 9:42-53.
22. Lee WJ, Yoo HS, Suh PG, Oh S, Lim JS, and Lee YM (2004) Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. Exp Mol Med 36:420-427.
23. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, and Spiegel S (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275:19513-19520.
24. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, and Schuler G (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92.
25. Maeda Y, Matsuyuki H, Shimano K, Kataoka H, Sugahara K, and Chiba K (2007) Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J Immunol 178:3437-3446.
26. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346-349.
27. Massberg S and von Andrian UH (2006) Fingolimod and sphingosine-1- phosphate-modifiers of lymphocyte migration. N Engl J Med 355:1088-1091.
28. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, and Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360.
29. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, et al. (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345-9350.
30. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, et al. (2002) Effects of FTY720 in MRL-1pr/1pr mice: therapeutic potential in systemic lupus erythematosus. J Rheumatol 29:707-716.
31. Pan S, Mi Y, Pally C, Beerli C, Chen A, Guerini D, Hinterding K, Nuesslein-Hildesheim B, Tuntland T, Lefebvre S, et al. (2006) A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol 13:1227-1234.
32. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, and Garcia JG (2004) Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169:1245-1251.
33. Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, and Zinkernagel RM (2000) FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164:5761-5770.
34. Rosen H, Alfonso C, Surh CD, and McHeyzer-Williams MG (2003) Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist. Proc Natl Acad Sci U S A 100:10907-10912.
35. Rosen H and Goetzl EJ (2005) Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5:560-570.
36. Sanna MG, Liao J, Jo E, Alfonso C, Ahn MY, Peterson MS, Webb B, Lefebvre S, Chun J, Gray N, et al. (2004) Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 279:13839-13848.
37. Sanna MG, Wang SK, Gonzalez-Cabrera PJ, Don A, Marsolais D, Matheu MP, Wei SH, Parker I, Jo E, Cheng WC, et al. (2006) Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2:434-441.
38. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, and Cyster JG (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739.
39. Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, Jo E, Wong CH, Parker I, and Cahalan MD (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6:1228-1235.
40. Yopp AC, Ochando JC, Mao M, Ledgerwood L, Ding Y, and Bromberg JS (2005) Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells. J Immunol 175:2913-2924.
41. Zemann B, Kinzel B, Müller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, and Billich A (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107:1454-1458.